PA-KNOPP-BIOSCIENCES-LLC
21.11.2018 12:26:39 CET | Business Wire | Press release
Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today announced that management will present at the Piper Jaffray 30th Annual Healthcare Conference to be held in New York, NY on November 27-29.
Michael Bozik, M.D., President and CEO of Knopp Biosciences, is scheduled to present on Tuesday, November 27th at 12:50 p.m. Eastern Time.
ABOUT KNOPP BIOSCIENCES LLC
Knopp Biosciences is a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need. Knopp’s clinical-stage small molecule, dexpramipexole, is entering Phase 3 clinical studies in hypereosinophilic syndrome and Phase 2 clinical studies in eosinophilic asthma. Knopp’s preclinical Kv7 platform is directed to small molecule treatments for neonatal epileptic encephalopathy, other rare epilepsies, tinnitus, and neuropathic pain. Please visit knoppbio.com .
This press release contains "forward-looking statements," including statements relating to planned regulatory filings and clinical development programs. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including the uncertainties inherent in clinical trials and product development programs, the availability of funding to support continued research and studies, the availability or potential availability of alternative therapies or treatments, the availability of patent protection for the discoveries and strategic alliances, as well as additional factors that may cause Knopp's actual results to differ from our expectations. There can be no assurance that any investigational drug product will be successfully developed or manufactured or that final results of clinical studies will be supportive of regulatory approvals required to market a product. Knopp undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.
Knopp's pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are still undergoing clinical study to verify their safety and effectiveness.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181121005061/en/
Contact:
MEDIA INQUIRIES: James Heins james.heins@icrinc.com +1.646.277.8251
INVESTOR INQUIRIES: Stephanie Carrington stephanie.carrington@icrinc.com +1.646.277.1282
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM and Uniphore Partner to Scale Domain-Specific AI Across Core Business Processes5.5.2026 15:15:00 CEST | Press release
Uniphore’s Business AI Cloud will power LTM’s BlueVerse™ ecosystem to deliver industry-specific small language models and AI agents for core enterprise workflows Uniphore, the Business AI Company, and LTM, the Business Creativity partner to the world's largest enterprises, today announced a strategic partnership focused on the joint development of industry- and domain-specific AI solutions that combine small language models (SLMs), AI agents, and deep domain expertise. As AI adoption matures, enterprises are shifting to smaller, purpose‑built models and agents for greater precision and control. The partnership brings this approach to core business processes with governance, security, and compliance by design. Uniphore’s Business AI Cloud will power LTM’s BlueVerse™ ecosystem and global delivery, unifying enterprise data, models, and AI agents on a secure, sovereign platform. LTM will drive industry expertise, client implementation, and AI‑led transformation, while Uniphore provides the
QuantWare Raises $178 Million to Build World’s Most Powerful Quantum Processors at an Industrial Scale5.5.2026 15:00:00 CEST | Press release
Largest private round by a dedicated industrial quantum processor company, Intel Capital and In-Q-Tel (IQT) participatingFunds VIO™ technology to deliver world’s most powerful processors for hyperscale quantum compute — and KiloFab, the world’s largest dedicated quantum open architecture fab QuantWare, the leading industrial quantum processor company, today announced a $178 million (€152 million) Series B equity funding round following the announcement of VIO-40K™, a quantum processor architecture for 10,000 qubits, 100x larger than the state of the art today. The company is building KiloFab, the world’s largest dedicated quantum open architecture fab, increasing the company’s production capacity by 20x to meet strong global customer demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505645970/en/ QuantWare co-founders Matthijs Rijlaarsdam (CEO) and Alessandro Bruno (CTO), pictured outside of QuantWare's KiloFab facil
Tacton, Award-Winning Innovation Leader, Launches AI Product Modeling Assistant to Accelerate CPQ Implementation and Eliminate Bottlenecks5.5.2026 15:00:00 CEST | Press release
New AI capability reduces product modeling effort by 50%, helping manufacturers bring complex products to market faster Tacton, a global leader in Configure, Price, Quote (CPQ) solutions for manufacturers of complex products, today announced the launch of AI Product Modeling Assistant, a new capability designed to dramatically accelerate product modeling and remove one of the most persistent barriers to CPQ success. Tacton’s AI Modeling Assistant is part of a core innovation to its CPQ platform, earning a Gold win in the 24th Annual American Business Awards for Most Innovative Tech Company of the Year. For manufacturers with highly configurable products, product modeling is often the longest and most resource-intensive phase of CPQ implementation. It determines how quickly products can be brought to market, how much of the portfolio is available at launch, and ultimately how fast organizations realize value from their CPQ investment. At the same time, many manufacturers face increasing
Tourism Surges in Oulu as European Capital of Culture Year Drives Record Visitor Numbers and Major Exhibitions5.5.2026 14:23:00 CEST | Press release
The European Capital of Culture year has boosted tourism and cultural attendance in Oulu, with strong growth in overnight stays, record-breaking visitor numbers and major exhibitions attracting local and international audiences. The year has started strongly in Oulu, Finland, with tourism and cultural attendance rising across sectors. In January–February, total overnight stays increased by more than 20%, while February alone saw a 32% increase, reaching 78,400 stays. International tourism grew by over 40%. At the same time, the opening festival in January attracted around 250,000 visits, highlighting strong interest among both residents and visitors and signalling a promising year for the city’s tourism sector. “The start of the year has clearly shown the power of culture in strengthening tourism and regional vitality,” says Oulu2026 Programme Director Samu Forsblom. “With hundreds of cultural operators across all 39 municipalities involved, this is a unique year to visit our region in
Fleet Launch Customer NetJets Takes Delivery of First Three Cessna Citation Ascend Midsize Business Jets5.5.2026 14:00:00 CEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, achieved a major milestone as the first three Cessna Citation Ascend business jets were delivered to fleet launch customer NetJets. NetJets, which operates the world's largest, most diverse private jet fleet, is the first private fleet operator to take delivery and begin operations with the Cessna Citation Ascend. Setting new standards in performance, comfort and operational efficiency for the midsize business jet market, the Citation Ascend builds on the longstanding relationship between Textron Aviation and NetJets by offering owners a seamless progression of advanced aircraft designed to deliver exceptional reliability, efficiency and luxury. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505495566/en/ Fleet launch customer NetJets takes delivery of first three Cessna Citation Ascend midsize business jets. (Photo Credit: Textron Aviation) “The Citation Ascend re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom